Susan B. Levy has over 30 years of global, cross-functional experience in the consumer healthcare industry and has worked on Rx to OTC switches since the mid ‘90s at SmithKline Beecham where she was involved with the Tagamet and Nicorette switches. At Warner-Lambert/Pfizer from 1996 to 2004 she served on the Switch Selection Team and the Switch Steering Team. Later, at Schering-Plough, Susan personally managed more than six development and exploratory phase switch programs with a total value exceeding $800MM.
In 2011, Susan founded her own consulting firm, Susan B. Levy Consulting, LLC. Since then, Susan and her team have worked on nearly 50 switch projects.
Susan received her BA in Chemistry from Cornell University and attended NYU’s Stern School of Business for her MBA.